{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:57:25Z","timestamp":1774364245824,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteoarthritis (OA) is a multifactorial joint disease characterized by cartilage degradation, chronic inflammation, and persistent pain, yet current treatments provide only symptomatic relief without altering disease progression. This study aimed to develop and evaluate an intra-articular co-delivery system of diacerein (DC) using solid lipid nanoparticles (SLN) and ketorolac (KT) incorporated into a hydrogel matrix (DC\u2013SLN gel) for synergistic cartilage protection and pain relief. SLN were optimized for particle size and polydispersity index by central composite design. In addition to zeta potential, entrapment efficiency, DSC, TEM, and stability assessment. The hydrogel composed of xanthan gum and sodium hyaluronate was characterized for rheological and in vitro release studies. In vitro release studies confirmed sustained DC release for prolonged chondroprotection and rapid KT release for acute analgesia. Therapeutic efficacy was evaluated in MIA-induced OA rats through behavioral assays, histological scoring, biochemical markers, and molecular analyses of inflammatory and chondrogenic pathways. DC\u2013SLN\/KT.gel demonstrated superior outcomes compared to free drugs or single-drug formulations. It significantly reduced pain behaviors, suppressed NF-\u03baB, IL-1\u03b2, CCL2, and Substance P, and lowered CD68\u207a macrophage infiltration. Concurrently, it preserved collagen II, inhibited MMP-13, and upregulated SOX-9 and miR-140, restoring cartilage homeostasis. In conclusion, embedding SLN within an injectable hydrogel enabled targeted, site-specific, and sustained intra-articular drug delivery, reducing systemic exposure while enhancing efficacy. These results demonstrate the DC\u2013SLN gel as a promising translational platform that unites targeted pain management with disease-modifying potential for advanced OA therapy.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13346-026-02088-8","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:40:19Z","timestamp":1774356019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intra-articular dual-targeted hydrogel co-delivering diacerein nanoparticles and ketorolac for modulating neuroimmune interplay and cartilage degeneration in osteoarthritis"],"prefix":"10.1007","author":[{"given":"Lamia A.","family":"Heikal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Gamal","family":"Abdel Nasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrine S.","family":"El-Mezayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragwa M.","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Etman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser M.","family":"Elkamary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2088_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7812\/TPP\/16-183","volume":"21","author":"MJ Lespasio","year":"2017","unstructured":"Lespasio MJ, et al. Knee osteoarthritis: a primer. Perm J. 2017;21:16\u2013183.","journal-title":"Perm J"},{"key":"2088_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.736688","volume":"16","author":"APA Dagnino","year":"2022","unstructured":"Dagnino APA, Campos MM. Chronic pain in the elderly: mechanisms and perspectives. Front Hum Neurosci. 2022;16: 736688.","journal-title":"Front Hum Neurosci"},{"key":"2088_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100597","volume":"19","author":"J Wen","year":"2023","unstructured":"Wen J, et al. Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Mater Today Bio. 2023;19: 100597.","journal-title":"Mater Today Bio"},{"issue":"2","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"C377","DOI":"10.1152\/ajpcell.00464.2022","volume":"324","author":"AE Rapp","year":"2023","unstructured":"Rapp AE, Zaucke F. Cartilage extracellular matrix-derived matrikines in osteoarthritis. Am J Physiol Cell Physiol. 2023;324(2):C377-c394.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2088_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/950192","volume":"2012","author":"T H\u00fcgle","year":"2012","unstructured":"H\u00fcgle T, et al. Aging and osteoarthritis: an inevitable encounter? J Aging Res. 2012;2012: 950192.","journal-title":"J Aging Res"},{"key":"2088_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ceb.2019.07.008","volume":"61","author":"V Lefebvre","year":"2019","unstructured":"Lefebvre V, Angelozzi M, Haseeb A. SOX9 in cartilage development and disease. Curr Opin Cell Biol. 2019;61:39\u201347.","journal-title":"Curr Opin Cell Biol"},{"key":"2088_CR7","doi-asserted-by":"crossref","unstructured":"Valenti MT et al. Control of the autophagy pathway in Osteoarthritis: Key regulators, therapeutic targets and therapeutic strategies. Int J Mol Sci. 2021;22(5),2700:1\u201315","DOI":"10.3390\/ijms22052700"},{"issue":"1","key":"2088_CR8","first-page":"261","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. Macrophages in osteoarthritis: pathophysiology and therapeutics. Am J Transl Res. 2020;12(1):261\u20138.","journal-title":"Am J Transl Res"},{"key":"2088_CR9","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.1016\/j.joca.2023.01.429","volume":"31","author":"D Amanitis","year":"2023","unstructured":"Amanitis D, et al. Knee osteoarthritis is associated with elevated Cd68 positive cells in dorsal root ganglia in humans. Osteoarthritis Cartilage. 2023;31:S378\u20139.","journal-title":"Osteoarthritis Cartilage"},{"key":"2088_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.conb.2019.11.006","volume":"62","author":"O Chen","year":"2020","unstructured":"Chen O, Donnelly CR, Ji RR. Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons. Curr Opin Neurobiol. 2020;62:17\u201325.","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"2088_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568\u201378.","journal-title":"JAMA"},{"issue":"4","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s13770-018-00176-6","volume":"16","author":"GI Im","year":"2019","unstructured":"Im GI. Perspective on intra-articular injection cell therapy for osteoarthritis treatment. Tissue Eng Regen Med. 2019;16(4):357\u201363.","journal-title":"Tissue Eng Regen Med"},{"key":"2088_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coph.2018.03.013","volume":"40","author":"MF Rai","year":"2018","unstructured":"Rai MF, Pham CT. Intra-articular drug delivery systems for joint diseases. Curr Opin Pharmacol. 2018;40:67\u201373.","journal-title":"Curr Opin Pharmacol"},{"key":"2088_CR14","doi-asserted-by":"crossref","unstructured":"Pavelka et al. Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs & aging. 2016;33(2):75-85.","DOI":"10.1007\/s40266-016-0347-4"},{"issue":"5","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00003088-199835050-00002","volume":"35","author":"P Nicolas","year":"1998","unstructured":"Nicolas P, et al. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet. 1998;35(5):347\u201359.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1166\/jbn.2013.1580","volume":"9","author":"A Jain","year":"2013","unstructured":"Jain A, et al. Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. J Biomed Nanotechnol. 2013;9(5):891\u2013900.","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.nano.2014.01.008","volume":"10","author":"A Jain","year":"2014","unstructured":"Jain A, et al. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomedicine. 2014;10(5):1031\u201340.","journal-title":"Nanomedicine"},{"key":"2088_CR18","doi-asserted-by":"crossref","unstructured":"Eladawy NO, Morsi NM, Shamma RN. Diacerein-loaded hyaluosomes as a dual-function platform for osteoarthritis management via intra-articular injection: In vitro characterization and in vivo assessment in a rat model. Pharmaceutics. 2021;13(6):765.","DOI":"10.3390\/pharmaceutics13060765"},{"issue":"1","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1527-3458.1996.tb00291.x","volume":"2","author":"FJ Flores-Murrieta","year":"1996","unstructured":"Flores-Murrieta FJ, Granados-Soto V. Pharmacologic properties of ketorolac tromethamine: a potent analgesic drug. CNS Drug Rev. 1996;2(1):75\u201390.","journal-title":"CNS Drug Rev"},{"issue":"8","key":"2088_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archinte.1993.00410080062009","volume":"153","author":"CJ Pearce","year":"1993","unstructured":"Pearce CJ, Gonzalez FM, Wallin JD. Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Intern Med. 1993;153(8):1000\u20132.","journal-title":"Arch Intern Med"},{"key":"2088_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.18203\/2349-2902.isj20220635","volume":"9","author":"V Verma","year":"2022","unstructured":"Verma V, et al. Outcome of intra-articular corticosteroid vs. intra-articular ketorolac in symptomatic knee osteo-arthritis: a retrospective study. International Surgery Journal. 2022;9:639.","journal-title":"International Surgery Journal"},{"key":"2088_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040191","author":"V Mishra","year":"2018","unstructured":"Mishra V, et al. Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10040191.","journal-title":"Pharmaceutics"},{"key":"2088_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.colsurfb.2015.02.046","volume":"128","author":"HR Kelidari","year":"2015","unstructured":"Kelidari HR, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;128:473\u20139.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2088_CR24","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.2147\/IJN.S67147","volume":"10","author":"M Rehman","year":"2015","unstructured":"Rehman M, et al. Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior. Int J Nanomedicine. 2015;10:2805\u201314.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/pharmaceutics3040954","volume":"3","author":"G Nava","year":"2011","unstructured":"Nava G, et al. Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine. Pharmaceutics. 2011;3(4):954\u201370.","journal-title":"Pharmaceutics"},{"key":"2088_CR26","doi-asserted-by":"crossref","unstructured":"Percie du Sert N et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"2088_CR27","doi-asserted-by":"publisher","first-page":"8353472","DOI":"10.1155\/2022\/8353472","volume":"2022","author":"HM Hamdalla","year":"2022","unstructured":"Hamdalla HM, et al. Ameliorative Effect of Curcumin Nanoparticles against Monosodium Iodoacetate-Induced Knee Osteoarthritis in Rats. Mediators Inflamm. 2022;2022:8353472.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2088_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbr.2012.01.001","volume":"229","author":"AJ Parent","year":"2012","unstructured":"Parent AJ, et al. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res. 2012;229(1):160\u20137.","journal-title":"Behav Brain Res"},{"issue":"6","key":"2088_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.30802\/AALAS-CM-19-000042","volume":"69","author":"PV Turner","year":"2019","unstructured":"Turner PV, Pang DS, Lofgren JL. A review of pain assessment methods in laboratory rodents. Comp Med. 2019;69(6):451\u201367.","journal-title":"Comp Med"},{"issue":"6","key":"2088_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16921","volume":"9","author":"X Liu","year":"2023","unstructured":"Liu X, et al. The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson\u2019s disease rat model. Heliyon. 2023;9(6): e16921.","journal-title":"Heliyon"},{"issue":"6","key":"2088_CR31","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1007\/s10787-023-01335-5","volume":"31","author":"YH Habib","year":"2023","unstructured":"Habib YH, et al. Hyaluronic acid\/diminazene aceturate combination ameliorates osteoarthritic anomalies in a rodent model: a role of the ACE2\/Ang1-7\/MasR axis. Inflammopharmacology. 2023;31(6):3263\u201379.","journal-title":"Inflammopharmacology"},{"issue":"3","key":"2088_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1017\/S0962728600005492","volume":"22","author":"JK Kirkwood","year":"2013","unstructured":"Kirkwood JK. AVMA guidelines for the euthanasia of animals. Anim Welf. 2013;22(3):412\u2013412.","journal-title":"Anim Welf"},{"issue":"8","key":"2088_CR33","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/cns.14179","volume":"29","author":"NS El-Mezayen","year":"2023","unstructured":"El-Mezayen NS, et al. Reactive astrocytes targeting with oral vitamin A: efficient neuronal regeneration for Parkinson\u2019s disease treatment and reversal of associated liver fibrosis. CNS Neurosci Ther. 2023;29(8):2111\u201328.","journal-title":"CNS Neurosci Ther"},{"key":"2088_CR34","doi-asserted-by":"publisher","first-page":"104228","DOI":"10.1016\/j.jddst.2023.104228","volume":"81","author":"A Mabrouk","year":"2023","unstructured":"Mabrouk A, et al. Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: Mechanistic insights. Journal of Drug Delivery Science and Technology. 2023;81:104228.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"2088_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122939","volume":"353","author":"AMA Mansour","year":"2024","unstructured":"Mansour AMA, et al. Valsartan as a prophylactic treatment against breast cancer development and niche activation: what molecular sequels follow chronic AT-1R blockade? Life Sci. 2024;353: 122939.","journal-title":"Life Sci"},{"key":"2088_CR36","doi-asserted-by":"crossref","unstructured":"Ibrahim RS et al. Biologically-Guided Isolation of Natural Lead Antithyroid Drug from Medicago sativa L. Sprouts and Its Toxic Profile in Comparison with Propylthiouracil. J Food Drug Anal. 2020;28(3):407\u201348.","DOI":"10.38212\/2224-6614.1242"},{"key":"2088_CR37","doi-asserted-by":"publisher","first-page":"121522","DOI":"10.1016\/j.lfs.2023.121522","volume":"319","author":"AF Bedair","year":"2023","unstructured":"Bedair AF, et al. Nicorandil reduces morphine withdrawal symptoms, potentiates morphine antinociception, and ameliorates liver fibrosis in rats. Life Sci. 2023;319:121522.","journal-title":"Life Sci"},{"issue":"1","key":"2088_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006;14(1):13\u201329.","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"2088_CR39","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.joca.2010.05.030","volume":"18","author":"N Gerwin","year":"2010","unstructured":"Gerwin N, et al. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage. 2010;18(Suppl 3):S24-34.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"2088_CR40","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1038\/s41598-024-61502-8","volume":"14","author":"I Takahashi","year":"2024","unstructured":"Takahashi I, et al. Histological and immunohistochemical analyses of articular cartilage during onset and progression of pre- and early-stage osteoarthritis in a rodent model. Sci Rep. 2024;14(1):10568.","journal-title":"Sci Rep"},{"issue":"1","key":"2088_CR41","doi-asserted-by":"publisher","first-page":"21658","DOI":"10.1038\/s41598-020-78757-6","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Characterization of regional meniscal cell and chondrocyte phenotypes and chondrogenic differentiation with histological analysis in osteoarthritic donor-matched tissues. Sci Rep. 2020;10(1):21658.","journal-title":"Sci Rep"},{"issue":"2-3","key":"2088_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2\u20133):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2088_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jpba.2006.01.020","volume":"41","author":"W Peter Wuelfing","year":"2006","unstructured":"Peter Wuelfing W, et al. Polysorbate 80 UV\/vis spectral and chromatographic characteristics \u2013 defining boundary conditions for use of the surfactant in dissolution analysis. J Pharm Biomed Anal. 2006;41(3):774\u201382.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"2088_CR44","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1080\/10717544.2022.2086937","volume":"29","author":"A Aguilera-Garrido","year":"2022","unstructured":"Aguilera-Garrido A, et al. Solid lipid nanoparticles to improve bioaccessibility and permeability of orally administered maslinic acid. Drug Deliv. 2022;29(1):1971\u201382.","journal-title":"Drug Deliv"},{"issue":"5","key":"2088_CR45","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/1061186X.2020.1722137","volume":"28","author":"S Sultana","year":"2020","unstructured":"Sultana S, et al. Stability issues and approaches to stabilised nanoparticles based drug delivery system. J Drug Target. 2020;28(5):468\u201386.","journal-title":"J Drug Target"},{"key":"2088_CR46","doi-asserted-by":"crossref","unstructured":"Singh A et al. Nanoengineered particles for enhanced intra-articular retention and delivery of proteins. Adv Healthc Mater. 2014;3(10):1562.","DOI":"10.1002\/adhm.201400051"},{"issue":"1\u20132","key":"2088_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","volume":"498","author":"J Pradal","year":"2016","unstructured":"Pradal J, et al. Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. Int J Pharm. 2016;498(1\u20132):119\u201329.","journal-title":"Int J Pharm"},{"issue":"11","key":"2088_CR48","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s12272-011-1109-9","volume":"34","author":"S Mitragotri","year":"2011","unstructured":"Mitragotri S, Yoo JW. Designing micro- and nano-particles for treating rheumatoid arthritis. Arch Pharm Res. 2011;34(11):1887\u201397.","journal-title":"Arch Pharm Res"},{"key":"2088_CR49","first-page":"2014","volume":"25","author":"R Shah","year":"2014","unstructured":"Shah R, et al. Optimization and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 2014;25:2014.","journal-title":"J Phys Sci"},{"key":"2088_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11746-010-1553-6","volume":"87","author":"C Trujillo","year":"2010","unstructured":"Trujillo C, Wright AJ. Properties and stability of solid lipid particle dispersions based on canola stearin and poloxamer 188. J Am Oil Chem Soc. 2010;87:715\u201330.","journal-title":"J Am Oil Chem Soc"},{"key":"2088_CR51","doi-asserted-by":"publisher","DOI":"10.4103\/1735-5362.199041","author":"S Salatin","year":"2017","unstructured":"Salatin S, et al. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Research in Pharmaceutical Sciences. 2017. https:\/\/doi.org\/10.4103\/1735-5362.199041.","journal-title":"Research in Pharmaceutical Sciences"},{"issue":"43","key":"2088_CR52","doi-asserted-by":"publisher","first-page":"36803","DOI":"10.1039\/C6RA02020H","volume":"6","author":"RM Shah","year":"2016","unstructured":"Shah RM, et al. Structure of solid lipid nanoparticles produced by a microwave-assisted microemulsion technique. RSC Adv. 2016;6(43):36803\u201310.","journal-title":"RSC Adv"},{"key":"2088_CR53","doi-asserted-by":"crossref","unstructured":"Singh E et al. Poly \u03b5-caprolactone nanoparticles for sustained intra-articular immune modulation in adjuvant-induced arthritis rodent model. Pharmaceutics. 2022;14.(3),519:1\u201322","DOI":"10.3390\/pharmaceutics14030519"},{"key":"2088_CR54","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.2147\/IJN.S139706","volume":"12","author":"A Allam","year":"2017","unstructured":"Allam A, Hamdallah S, Abdallah O. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo\/in vivo evaluation. Int J Nanomedicine. 2017;12:4733\u201345.","journal-title":"Int J Nanomedicine"},{"key":"2088_CR55","doi-asserted-by":"crossref","unstructured":"Ebrahimi H, et al. Repaglinide-loaded solid lipid nanoparticles: Effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles. DARU J Pharm Sci 2015;23(46):1\u201311","DOI":"10.1186\/s40199-015-0128-3"},{"key":"2088_CR56","first-page":"1137","volume":"61","author":"M Ibrahim","year":"2013","unstructured":"Ibrahim M, et al. Performance of poloxamer 407 as hydrophilic carrier on the binary mixtures with nimesulide. Farmacia. 2013;61:1137.","journal-title":"Farmacia"},{"issue":"Suppl 1","key":"2088_CR57","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54(Suppl 1):S131\u201355.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2088_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.21037\/atm-22-818","volume":"10","author":"Z Cai","year":"2022","unstructured":"Cai Z, et al. A narrative review of the progress in the treatment of knee osteoarthritis. Ann Transl Med. 2022;10(6):373.","journal-title":"Ann Transl Med"},{"key":"2088_CR59","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.12659\/MSM.916092","volume":"25","author":"J Li","year":"2019","unstructured":"Li J, et al. Xanthan gum ameliorates osteoarthritis and mitigates cartilage degradation via regulation of the Wnt3a\/\u03b2-catenin signaling pathway. Med Sci Monit. 2019;25:7488\u201398.","journal-title":"Med Sci Monit"},{"key":"2088_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12891-015-0775-z","volume":"16","author":"RD Altman","year":"2015","unstructured":"Altman RD, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"2088_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2165\/00003495-199039010-00008","volume":"39","author":"MM Buckley","year":"1990","unstructured":"Buckley MM, Brogden RN. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1990;39(1):86\u2013109.","journal-title":"Drugs"},{"key":"2088_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4314\/njpr.v16i1.3","volume":"16","author":"M Ilomuanya","year":"2020","unstructured":"Ilomuanya M, et al. Silver sulphadiazine- xanthan gum- hyaluronic acid composite hydrogel for wound healing: formulation development and in vivo evaluation. Niger J Pharm Res. 2020;16:21\u20139.","journal-title":"Niger J Pharm Res"},{"key":"2088_CR63","doi-asserted-by":"crossref","unstructured":"Anu\u021ba V, et al. Novel Buccal Xanthan Gum-Hyaluronic Acid Eutectogels with Dual Anti-Inflammatory and Antimicrobial Properties. Gels. 2025;11(3),208:1\u201350","DOI":"10.3390\/gels11030208"},{"key":"2088_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.31024\/ajpp.2023.9.5.2","volume":"9","author":"K Lowanshi","year":"2023","unstructured":"Lowanshi K, Pawar R. Formulation and evaluation of ketorolac hydrogel for effective management of dermatitis. Asian J Pharm Pharmacol. 2023;9:153\u20138.","journal-title":"Asian J Pharm Pharmacol"},{"key":"2088_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/gels8110723","author":"M Koland","year":"2022","unstructured":"Koland M, et al. Thermosensitive in situ gels for joint disorders: pharmaceutical considerations in intra-articular delivery. Gels. 2022. https:\/\/doi.org\/10.3390\/gels8110723.","journal-title":"Gels"},{"key":"2088_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/polym17172397","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. Fabrication of thixotropic polymeric gel system and its gelation mechanism. Polymers (Basel). 2025. https:\/\/doi.org\/10.3390\/polym17172397.","journal-title":"Polymers (Basel)"},{"key":"2088_CR67","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhazmat.2012.11.028","volume":"244\u2013245","author":"L Zhong","year":"2013","unstructured":"Zhong L, et al. Rheological behavior of xanthan gum solution related to shear thinning fluid delivery for subsurface remediation. J Hazard Mater. 2013;244\u2013245:160\u201370.","journal-title":"J Hazard Mater"},{"key":"2088_CR68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jbm.a.30623","volume":"76","author":"S Falcone","year":"2006","unstructured":"Falcone S, Palmeri D, Berg R. Rheological and cohesive properties of hyaluronic acid. J Biomed Mater Res A. 2006;76:721\u20138.","journal-title":"J Biomed Mater Res A"},{"issue":"6","key":"2088_CR69","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/gels9060469","volume":"9","author":"L Budai","year":"2023","unstructured":"Budai L, et al. Rheological considerations of pharmaceutical formulations: focus on viscoelasticity. Gels. 2023;9(6):469.","journal-title":"Gels"},{"issue":"2","key":"2088_CR70","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/acs.chemrev.2c00179","volume":"123","author":"P Bertsch","year":"2023","unstructured":"Bertsch P, et al. Self-healing injectable hydrogels for tissue regeneration. Chem Rev. 2023;123(2):834\u201373.","journal-title":"Chem Rev"},{"issue":"12","key":"2088_CR71","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1021\/acsbiomaterials.7b00734","volume":"3","author":"MH Chen","year":"2017","unstructured":"Chen MH, et al. Methods to assess shear-thinning hydrogels for application as injectable biomaterials. ACS Biomater Sci Eng. 2017;3(12):3146\u201360.","journal-title":"ACS Biomater Sci Eng"},{"issue":"3","key":"2088_CR72","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/antiox12030633","volume":"12","author":"E Subroto","year":"2023","unstructured":"Subroto E, Andoyo R, Indiarto R. Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants. 2023;12(3):633.","journal-title":"Antioxidants"},{"key":"2088_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2017.08.006","volume":"267","author":"T Thambi","year":"2017","unstructured":"Thambi T, Li Y, Lee DS. Injectable hydrogels for sustained release of therapeutic agents. J Control Release. 2017;267:57\u201366.","journal-title":"J Control Release"},{"issue":"1","key":"2088_CR74","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1080\/21655979.2021.1988364","volume":"12","author":"C Lv","year":"2021","unstructured":"Lv C, et al. Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway. Bioengineered. 2021;12(1):8635\u201349.","journal-title":"Bioengineered"},{"issue":"5","key":"2088_CR75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7555\/JBR.29.20130092","volume":"29","author":"A Jain","year":"2015","unstructured":"Jain A, et al. Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats. J Biomed Res. 2015;29(5):405\u201313.","journal-title":"J Biomed Res"},{"key":"2088_CR76","doi-asserted-by":"publisher","first-page":"119249","DOI":"10.1016\/j.ijpharm.2020.119249","volume":"581","author":"J Jung","year":"2020","unstructured":"Jung J, et al. A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis. Int J Pharm. 2020;581:119249.","journal-title":"Int J Pharm"},{"issue":"2","key":"2088_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.56718\/ijp.23-010","volume":"14","author":"J Han","year":"2023","unstructured":"Han J, Park D, Han S. Animal models in osteoarthritis research: pain behavioral methods and clinical significance. Int J Pain. 2023;14(2):39\u201347.","journal-title":"Int J Pain"},{"issue":"6","key":"2088_CR78","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.joca.2022.01.010","volume":"30","author":"M Alves-Sim\u00f5es","year":"2022","unstructured":"Alves-Sim\u00f5es M. Rodent models of knee osteoarthritis for pain research. Osteoarthritis Cartilage. 2022;30(6):802\u201314.","journal-title":"Osteoarthritis Cartilage"},{"key":"2088_CR79","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.2147\/IJN.S423737","volume":"18","author":"L Liu","year":"2023","unstructured":"Liu L, Tang H, Wang Y. Nanotechnology-boosted biomaterials for osteoarthritis treatment: current status and future perspectives. Int J Nanomedicine. 2023;18:4969\u201383.","journal-title":"Int J Nanomedicine"},{"issue":"13","key":"2088_CR80","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.7150\/thno.55664","volume":"11","author":"MR Iaquinta","year":"2021","unstructured":"Iaquinta MR, et al. The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. Theranostics. 2021;11(13):6573\u201391.","journal-title":"Theranostics"},{"issue":"1","key":"2088_CR81","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41413-022-00239-4","volume":"11","author":"X Du","year":"2023","unstructured":"Du X, et al. The role of TGF-beta3 in cartilage development and osteoarthritis. Bone Res. 2023;11(1):2.","journal-title":"Bone Res"},{"issue":"1","key":"2088_CR82","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2457520","volume":"57","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang Z. Therapeutic potential of SOX family transcription factors in osteoarthritis. Ann Med. 2025;57(1): 2457520.","journal-title":"Ann Med"},{"issue":"3","key":"2088_CR83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00011-009-0085-8","volume":"59","author":"JS Pasin","year":"2010","unstructured":"Pasin JS, et al. Diacerein decreases TNF-alpha and IL-1beta levels in peritoneal fluid and prevents Baker\u2019s yeast-induced fever in young rats. Inflamm Res. 2010;59(3):189\u201396.","journal-title":"Inflamm Res"},{"issue":"1","key":"2088_CR84","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15386\/mpr-1422","volume":"93","author":"OM Zahan","year":"2020","unstructured":"Zahan OM, et al. The evaluation of oxidative stress in osteoarthritis. Med Pharm Rep. 2020;93(1):12\u201322.","journal-title":"Med Pharm Rep"},{"issue":"2","key":"2088_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1759720X09359104","volume":"2","author":"J Martel-Pelletier","year":"2010","unstructured":"Martel-Pelletier J, Pelletier JP. Effects of diacerein at the molecular level in the osteoarthritis disease process. Ther Adv Musculoskelet Dis. 2010;2(2):95\u2013104.","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02088-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:04:09Z","timestamp":1774361049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02088-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":85,"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02088-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ethical approval for the animal work was granted by the Institutional Animal Care and Use, Committee of Alexandria University (AU 06\u20132023-4\u201312-2\u2013152), and all procedures complied with ARRIVE guidelines governing the ethical use and care of laboratory animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The authors have no relevant financial or non-financial interests to disclose\n                      .","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}